GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio Preventive Medicine Corp (ROCO:6810) » Definitions » Debt-to-Revenue

Bio Preventive Medicine (ROCO:6810) Debt-to-Revenue : 116.24 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Bio Preventive Medicine Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Bio Preventive Medicine's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$7.25 Mil. Bio Preventive Medicine's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$106.20 Mil. Bio Preventive Medicine's annualized Revenue for the quarter that ended in Dec. 2023 was NT$0.98 Mil. Bio Preventive Medicine's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 116.24.


Bio Preventive Medicine Debt-to-Revenue Historical Data

The historical data trend for Bio Preventive Medicine's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio Preventive Medicine Debt-to-Revenue Chart

Bio Preventive Medicine Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial N/A N/A 6.58 56.00 93.91

Bio Preventive Medicine Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.29 0.90 54.18 81.53 116.24

Competitive Comparison of Bio Preventive Medicine's Debt-to-Revenue

For the Biotechnology subindustry, Bio Preventive Medicine's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio Preventive Medicine's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio Preventive Medicine's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bio Preventive Medicine's Debt-to-Revenue falls into.



Bio Preventive Medicine Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Bio Preventive Medicine's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(7.247 + 106.2) / 1.208
=93.91

Bio Preventive Medicine's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(7.247 + 106.2) / 0.976
=116.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.


Bio Preventive Medicine Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bio Preventive Medicine's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio Preventive Medicine (ROCO:6810) Business Description

Traded in Other Exchanges
N/A
Address
No.18, Taiyuan Street, 1 of 6th Floor, Hsinchu County, Zhubei, TWN, 30265
Bio Preventive Medicine Corp is an innovative clinical-staged biotech company, focusing on early detection and prevention of diseases specialty of those high value added molecular diagnostic product.

Bio Preventive Medicine (ROCO:6810) Headlines

No Headlines